OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC Logo

OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC

A former biopharma firm that developed cannabinoid-based pain medicines.

OCTHF | IL

Overview

Corporate Details

ISIN(s):
GB00BMVMRB86
LEI:
2138005SRWT4998BCE35
Country:
United Kingdom
Address:
PRAMA HOUSE, 267 BANBURY ROAD, OX2 7HT OXFORD

Description

Oxford Cannabinoid Technologies Holdings PLC was a biopharmaceutical company engaged in the research, development, and commercialization of cannabinoid-based prescription medicines. The company's primary focus was on the pain market, with the goal of developing non-addictive medications to reduce reliance on opioids. Its drug discovery programs targeted the endocannabinoid system (ECS) and included a portfolio of proprietary cannabinoid derivatives, in-licensed compounds, and new chemical entities. According to its website, the company ceased trading and entered administration in May 2025.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-06-06 08:00
Cancellation of Listing
English 10.0 KB
2024-05-31 08:00
Updated Shareholder Engagement
English 10.6 KB
2024-05-17 17:30
Updated Shareholder Information
English 22.6 KB
2024-05-08 08:00
Intended Cancellation of Listing
English 32.1 KB
2024-04-11 12:26
Appointment of Phase I Clinical Trial CRO
English 17.3 KB
2024-04-03 09:00
OCT Company Update with Doceo
English 7.4 KB
2024-03-26 11:56
Oxford Cannabinoid Technologies video with Doceo
English 6.9 KB
2024-03-18 08:00
Appointment of Hybridan as Adviser
English 14.2 KB
2024-02-29 08:02
Directorate Appointment
English 15.3 KB
2024-02-29 08:01
Directorate Changes
English 16.2 KB
2024-02-29 08:00
Total Voting Rights
English 11.8 KB
2024-02-28 18:35
TR-1: NOTIFICATION OF MAJOR HOLDINGS
English 65.2 KB
2024-02-28 18:34
TR-1: NOTIFICATION OF MAJOR HOLDINGS
English 71.7 KB
2024-02-28 18:34
TR-1: NOTIFICATION OF MAJOR HOLDINGS
English 65.4 KB
2024-02-26 14:07
Directors’ Dealings
English 40.8 KB

Automate Your Workflow. Get a real-time feed of all OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Bioversys N Logo
Clinical-stage biopharma developing antibacterial therapies for antimicrobial resistance.
Switzerland
BIOV
BIOVIE INC. Logo
Develops drug therapies for neurological disorders and advanced liver disease.
United States of America
BIVI
BioXcel Therapeutics, Inc. Logo
Biopharmaceutical company using AI to develop drugs for neuroscience and immuno-oncology.
United States of America
BTAI
Black Diamond Therapeutics, Inc. Logo
Develops precision oncology therapies targeting families of oncogenic mutations.
United States of America
BDTX
BL Pharmtech Corp. Logo
Researches, develops, and sells health foods, supplements, and pharmaceuticals.
South Korea
065170
BNC Korea Co, Ltd Logo
Develops hyaluronic acid-based dermal fillers and botulinum toxin injectables.
South Korea
256840
Boditech Med Inc. Logo
Develops, manufactures, and distributes in-vitro diagnostic (IVD) solutions.
South Korea
206640
BOIRON Logo
A family-owned pharmaceutical laboratory and a world leader in homeopathic medicines.
France
BOI
Manufactures specialty ingredients for the food, pharmaceutical, and cosmetic industries.
South Korea
002760
Bolt Biotherapeutics, Inc. Logo
Clinical-stage biotech developing immuno-oncology therapies using the innate immune system.
United States of America
BOLT

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.